Filing Details
- Accession Number:
- 0001415889-25-014186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-22 17:00:13
- Reporting Period:
- 2025-05-20
- Filing Date:
- 2025-05-22
- Accepted Time:
- 2025-05-22 17:00:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671858 | Ars Pharmaceuticals Inc. | SPRY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398595 | A Alexander Fitzpatrick | C/O Ars Pharmaceuticals, Inc. 11682 El Camino Real, Suite 120 San Diego CA 92130 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-20 | 100,000 | $5.58 | 192,582 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-20 | 102,969 | $14.10 | 89,613 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-05-20 | 100,000 | $0.00 | 100,000 | $5.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,000 | 2034-01-01 | No | 4 | M | Direct |
Footnotes
- Includes 3,355 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2024.
- The weighted average sale price for the transaction reported was $14.0966 and the range of prices were between $14.02 and $14.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- 25% of the shares subject to the option vested on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.
Billionaire Hedge Funds
